Skip to main content

Advertisement

Table 2 Correlation between VASH2 and histopathologic features in 102 cases of pancreatic cancer

From: Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2

Category n (%) VASH2 staining (%) P value1
Negative/weak Middle/strong
Adjacent tissues 102 77(75.5) 25(24.5) 0.001
Cancer tissue 102 44(43.1) 58(56.9)
Tumor Grade
 G1-G2 48 (47.1) 27(56.2) 21(43.8) 0.012
 G3 54 (52.9) 17(31.5) 37(68.5)
Pathologic stage
 T1-2 15(14.7) 5(33.3) 10(66.7) 0.406
 T3-4 87(85.3) 39(44.8) 48(55.2)
Node status
 Negative 57(55.9) 20(35.1) 37(64.9) 0.065
 Positive 45(44.1) 24(53.3) 21(46.7)
Nerve status
 Negative 34(33.3) 16(47.1) 18(52.9) 0.572
 Positive 68(66.7) 28(41.2) 40(58.8)
Vessel cancerous embolus
 Negative 89(87.3) 42(47.2) 47(52.8) 0.031
 Positive 13(12.7) 2(15.4) 11(84.6)
  1. 1Pearson’s chi-square test p-value